20 May 2013
Keywords: correction, novartis, aclasta, article, published, on-line, july
Article | 30 July 2007
In an article published on-line on July 20, we incorrectly stated that Novartis' Aclasta (zoledronic acid) is approved for the treatment ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 July 2007
© 2013 thepharmaletter.com